glp 1 vs metformin GLP-1 RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Diabetes: Are GLP-1s or metformin

Description

Now that the supply has stabilized, the FDA has removed GLP-1 therapies from the national shortage list, suggesting these medications should be easier to access

If you develop symptoms suggestive of diverticulitis whilst taking Wegovy, this should be evaluated on its own merits rather than automatically attributed to the medication

Here is what GLP-1 clients commonly experience that the prescription insert glosses over: Ozempic face & body : rapid fat loss without skin support leads to sagging, hollowness, and a drawn, aged appearance Muscle wasting : the body breaks down lean tissue when protein intake drops and no targeted support is in place Digestive disruption : GLP-1 medications slow gastric emptying, causing bloating, constipation, and general GI discomfort Fatigue : eating less means less fuel, and without metabolic support, energy levels drop significantly Emotional flatness : rapid body changes, hormonal shifts, and reduced food reward create a kind of low-grade emotional numbness many clients do not expect Plateaus : the body adapts, metabolism slows, and weight loss stalls even when the medication is working None of this means GLP-1 medications are wrong for you